ABK Biomedical and MURR Forge Long-Term Partnership to Advance Breakthrough Cancer Therapy

HALIFAX, NS, March 31, 2026 /PRNewswire/ - ABK Biomedical and the University of Missouri Research Reactor (MURR) are powering the next generation of cancer treatment. Today, the two partners signed a long-term agreement naming MURR as the primary irradiation partner for Eye90...